GBA1 and Parkinson disease: Additionally, single-cell RNA sequencing and proteomics of brain samples from GBA-PD patients confirmed reduced CMA activity and proteome changes comparable to those found in brain samples from heterozygous L444P/N GBA1 mice [49].